Zhangzhou Pientzehuang Pharmaceutical | 600436 - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Jiangsu Hengrui CNY 37.1M 6.2M 2026-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Moderna USD 610M 584M 2025-12
Revvity USD 2.63B 543K 2025-12
Sh Fosun Pharma CNY 15.95B 562.19M 2026-03
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Wuxi Apptec CNY 2.27B 475.26M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03